Evidence map›Paper›PMID 22913772›Full record

ArticleBiochemistry2012

Reactive cysteine in the structural Zn(2+) site of the C1B domain from PKCα.

Mikaela D Stewart, Tatyana I Igumenova

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Folding and unfolding dynamics of a DNA aptamer studied by heteronuclearJournal of magnetic resonance (San Diego, Calif. : 1997) · 2026
    Article
  2. Article
  3. Article
  4. Uncovering ZnThe Journal of biological chemistry · 2023
    Article
  5. Article
  6. Protein Lipoxidation: Basic Concepts and Emerging Roles.Antioxidants (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mikaela D StewartDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843-2128, United States.
Tatyana I Igumenova
Texas A&M University · US

Funding

Graduate Training in Molecular BiophysicsT32GM065088 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI REINHART, GREGORY DUNCAN · 2003 to 2007
$572k
NIGMS NIH HHS 5-T32GM065088NIGMS NIH HHS T32 GM065088
6 · The paper itself

Abstract

Structural cysteine-rich Zn(2+) sites that stabilize protein folds are considered to be unreactive. In this article, we identified a reactive cysteine residue, Cys151, in a treble-clef zinc finger with a Cys(3)His coordination sphere. The protein in question is the C1B domain of Protein Kinase Cα (PKCα). Mass-tagging cysteine assays of several C1B variants were employed to ascertain the site specificity of the covalent modification. The reactivity of Cys151 in C1B also manifests itself in the structural dynamics of the Zn(2+) coordination sphere where the Sγ of Cys151 alternates between the Zn(2+)-bound thiolate and free thiol states. We used NMR-detected pH titrations, ZZ-exchange spectroscopy, and residual dipolar coupling (RDC)-driven structure refinement to characterize the two exchanging conformations of C1B that differ in zinc coordination. Our data suggest that Cys151 serves as an entry point for the reactive oxygen species that activate PKCα in a process involving Zn(2+) release.

Indexed as

AnimalsBinding SitesCysteineMiceNuclear Magnetic Resonance, BiomolecularProtein Kinase C-alphaProtein Structure, TertiaryReactive Oxygen SpeciesZincZinc FingersCysteinePrkca protein, mouseProtein Kinase C-alphaReactive Oxygen SpeciesZinc

Identifiers

PMID22913772
PMCPMC3645944
OpenAlexW2062077721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.